PATENT CLAIM ANALYSIS

Application Number: 15923470
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2018-10
Patent Classification: ["514", "056000"]

Abstract:
Methods are presented for attenuating myelosuppressive side effects of treatment regimens, promoting thrombopoiesis and neutrophil production, and increasing efficacy of treatment regimens, by administering PF4-interacting heparinoids.

Claim (Index 1):
A method of attenuating a myelosuppressive side effect of a patient treatment regimen comprising:\n adjunctively administering a therapeutically effective amount of a PF4-interacting heparinoid to the patient.

Metadata:
- Claim Count in Document: 1.0
- Percentile: 90.0
- Lexical Diversity: 1.25
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['13801990', '13963526', '15044740', '14951353', '14936464']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.684669350661657
- 35 USC 102 Novelty (BERT): 0.6591038102783121
- Combined Prediction Score: 0.6821127966233226
- Mean Citation Score: 420.533876
- Max Citation Score: 714.25195
- Similarity Product: 580.7986054646312

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test